Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.4% |
| 2 | Technology | 3.32% |
| 3 | Consumer Discretionary | 2.87% |
| 4 | Financials | 2.84% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
PUT
Lyft
LYFT
$6.28B
| $32.7M | 0.01% |
989,500
-437,800
| -31% | -$13.8M |
|
1027
Arcturus Therapeutics
ARCT
$223M
| $32.6M | 0.01% |
698,284
+683,546
| +4,638% | +$23.6M |
|
1028
Targa Resources
TRGP
$57.6B
| $32.6M | 0.01% |
1,623,215
-5,006,824
| -76% | -$75.3M |
|
|
DRE
1029
DELISTED
Duke Realty Corp.
DRE
| $32.4M | 0.01% |
916,204
+364,882
| +66% | +$12.5M |
|
1030
Bath & Body Works
BBWI
$3.65B
| $32.4M | 0.01% |
2,673,312
-2,675,262
| -50% | -$29.8M |
|
1031
CALL
Illinois Tool Works
ITW
$83.3B
| $32.3M | 0.01% |
184,900
+28,700
| +18% | +$4.69M |
|
1032
PUT
VanEck Oil Services ETF
OIH
$1.95B
| $32.3M | 0.01% |
265,000
+236,480
| +829% | +$26.5M |
|
1033
Thor Industries
THO
$4.11B
| $32.3M | 0.01% |
302,939
+72,842
| +32% | +$5.7M |
|
1034
CALL
Datadog
DDOG
$90.6B
| $32.3M | 0.01% |
371,100
+94,900
| +34% | +$5.78M |
|
1035
CALL
O'Reilly Automotive
ORLY
$74.5B
| $32.2M | 0.01% |
1,146,000
+285,000
| +33% | +$7.45M |
|
|
PXD
1036
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $32.1M | 0.01% |
328,900
+134,900
| +70% | +$11.9M |
|
1037
PUT
PPG Industries
PPG
$25.5B
| $32.1M | 0.01% |
302,700
+248,600
| +460% | +$23.9M |
|
1038
Performance Food Group
PFGC
$16.9B
| $32.1M | 0.01% |
1,101,487
+724,398
| +192% | +$18.8M |
|
1039
CenterPoint Energy
CNP
$26.7B
| $32.1M | 0.01% |
1,717,781
-9,064,045
| -84% | -$156M |
|
1040
Boston Beer
SAM
$1.89B
| $32M | 0.01% |
59,710
-93,884
| -61% | -$45.5M |
|
1041
West Pharmaceutical
WST
$24.8B
| $32M | 0.01% |
141,025
+128,809
| +1,054% | +$25.3M |
|
1042
CALL
Align Technology
ALGN
$12.4B
| $32M | 0.01% |
116,500
+20,200
| +21% | +$4.55M |
|
1043
CALL
Inovio Pharmaceuticals
INO
$93M
| $32M | 0.01% |
98,817
+25,975
| +36% | +$4.17M |
|
|
ADAP
1044
DELISTED
Adaptimmune Therapeutics
ADAP
| $31.9M | 0.01% |
3,189,168
+1,135,963
| +55% | +$7.13M |
|
1045
VanEck Gold Miners ETF
GDX
$26.9B
| $31.9M | 0.01% |
869,046
-871,657
| -50% | -$28.7M |
|
1046
CALL
Phillips 66
PSX
$90B
| $31.8M | 0.01% |
442,200
+162,100
| +58% | +$11.5M |
|
1047
Enphase Energy
ENPH
$5.39B
| $31.8M | 0.01% |
668,040
+127,574
| +24% | +$6.1M |
|
|
NBL
1048
DELISTED
Noble Energy, Inc.
NBL
| $31.7M | 0.01% |
3,542,690
-13,193,357
| -79% | -$118M |
|
1049
Xcel Energy
XEL
$49.1B
| $31.7M | 0.01% |
507,206
+362,045
| +249% | +$22.8M |
|
1050
Sysco
SYY
$40.5B
| $31.6M | 0.01% |
578,234
-324,919
| -36% | -$17.1M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.